← All trials
NCT06504381
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2024
- Primary completion
- Jan 31, 2040
- Completion date
- Jan 31, 2040
- First posted
- Jul 16, 2024
- Last posted
- Oct 23, 2024
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of California, San FranciscoLead sponsor
- California Institute for Regenerative Medicine (CIRM)Official
- California Institute for Regenerative Medicine (CIRM)Collaborator
- University of California, San FranciscoOfficial
- University of California, San FranciscoSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.